Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease.
Merle M, Fischbacher D, Liepert A, Grabrucker C, Kroell T, Kremser A, Dreyssig J, Freudenreich M, Schuster F, Borkhardt A, Kraemer D, Koehne CH, Kolb HJ, Schmid C, Schmetzer HM.
Merle M, et al. Among authors: liepert a.
Immunol Invest. 2020 May;49(4):365-385. doi: 10.1080/08820139.2019.1661429. Epub 2019 Sep 19.
Immunol Invest. 2020.
PMID: 31535582